What Is the Risk-Benefit Ratio of Long-Term Antipsychotic Treatment in People With Schizophrenia?

World Psychiatry - United States
doi 10.1002/wps.20516
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Long-Term Treatment With Clozapine in Schizophrenia

British Journal of Psychiatry
MedicinePsychiatryMental Health
1996English

What Is the Role of Long-Acting Injectable Antipsychotics in the Treatment of Schizophrenia?

Journal of Clinical Psychiatry
MedicinePsychiatryMental Health
2014English

The Long-Term Treatment of Schizophrenia With Antipsychotics: A Perennial Debate

World Psychiatry
PsychiatryMental HealthPsychiatric Mental Health
2018English

Designing a Long-Term Supportive Housing Facility for People With Schizophrenia

English

Measurement of Treatment Adherence With Antipsychotic Agents in Patients With Schizophrenia

Neuropsychiatric Disease and Treatment
PsychiatryMental HealthBiological Psychiatry
2009English

Comparison of Antipsychotic Medication Effects on Reducing Violence in People With Schizophrenia

British Journal of Psychiatry
MedicinePsychiatryMental Health
2008English

Clinical and Psychosocial Remission in Schizophrenia: Correlations With Antipsychotic Treatment

BMC Psychiatry
PsychiatryMental Health
2012English

Clinical Efficacy of Antipsychotic Drugs in the Treatment of Schizophrenia

Journal of Cytology & Histology
2014English

Antipsychotic Treatment Patterns and Hospitalizations Among Adults With Schizophrenia

Schizophrenia Research
PsychiatryMental HealthBiological Psychiatry
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy